$10 billion raised to fund development of coronavirus vaccine

Publié: 26th mai 2020

Commenting on the announcement by the European Commission that $10.4 billion had been raised to fund the research and development of vaccines, treatments and tests for the coronavirus, Anna Marriott, Health Policy Manager for Oxfam said:

“Most people will be happy to see public funds invested in the development of vaccines for the coronavirus. But governments must be clear about how this money is spent, and what conditions they are attaching to ensure that any eventual vaccine is distributed according to need, and made available to every individual, in every nation, free of charge. Vaccines should be a public good ―not the private property of the pharmaceutical industry.”

Notes aux rédactions

The Coronavirus Global Response pledging marathon was launched on 4 May 2020.


Anna Ratcliff in Oxford, UK | anna.ratcliff@oxfam.org | +44 7796 993288
Annie Thériault in Montreal, Canada | annie.theriault@oxfam.org | +51 936 307 990

For updates, please follow @Oxfam.

Sign the petition now: When a COVID-19 vaccine is found, it must be free and fairly distributed to everyone on the planet.

Please support Oxfam's Coronavirus Response Appeal.